−0.44USD
−19.17 MUSD
44.86 MUSD
43.75 M
About Augmedix, Inc.
Sector
CEO
Emmanuel Krakaris
Website
Headquarters
San Francisco
Employees (FY)
1.43 K
Founded
2012
FIGI
BBG006674MJ1
Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. It offers live support including referrals, orders, and reminders that allow clinicians to focus on patient care. The company was founded by Ian Shakil in 2012 and is headquartered in San Francisco, CA.
Decade of DecadenceThis Tasty Treat is at the bottom of the Channel, as you can See. Springboard, with that Strong Marubozu. I dont Even have to Tell you, What's Next...!
$AUGX - NEW MARKET STRCUTUREAs usual, charts speak louder than words.
This one is shouting the following:
- Steady downtrending market since its IPO, as delimited by the yellow trendline, with several key touches.
- Trendline broken in December 2023.
- Breakout above the 10 EMA (roughly 200 EMA in the daily timeframe)
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AUGX is 2.94 USD — it has increased by 3.52% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Augmedix, Inc. stocks are traded under the ticker AUGX.
Augmedix, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
AUGX stock is 6.64% volatile and has beta coefficient of 1.40. Check out the list of the most volatile stocks — is Augmedix, Inc. there?
AUGX earnings for the last quarter are −0.10 USD per share, whereas the estimation was −0.12 USD resulting in a 13.04% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about Augmedix, Inc. earnings.
Augmedix, Inc. revenue for the last quarter amounts to 11.77 M USD despite the estimated figure of 11.43 M USD. In the next quarter revenue is expected to reach 12.46 M USD.
Yes, you can track Augmedix, Inc. financials in yearly and quarterly reports right on TradingView.
AUGX stock has fallen by 15.76% compared to the previous week, the month change is a 25.57% fall, over the last year Augmedix, Inc. has showed a 2.00% decrease.
AUGX net income for the last quarter is −4.49 M USD, while the quarter before that showed −4.41 M USD of net income which accounts for −1.91% change. Track more Augmedix, Inc. financial stats to get the full picture.
Today Augmedix, Inc. has the market capitalization of 138.42 M, it has decreased by 13.33% over the last week.
No, AUGX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AUGX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Augmedix, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 1.43 K employees. See our rating of the largest employees — is Augmedix, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Augmedix, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Augmedix, Inc. stock shows the sell signal. See more of Augmedix, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Augmedix, Inc. future price: according to them, AUGX price has a max estimate of 8.00 USD and a min estimate of 5.00 USD. Read a more detailed Augmedix, Inc. forecast: see what analysts think of Augmedix, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Augmedix, Inc. EBITDA is −17.21 M USD, and current EBITDA margin is −39.42%. See more stats in Augmedix, Inc. financial statements.